4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-22-059053
10% owner acquired 7,176 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pontifax Management 4 G.P. (2015) Ltd. 10% owner | 2022-11-29 | Option exercise | −3,539 | $0.00 | $0 | 2,284,612 | I |
| Pontifax Management 4 G.P. (2015) Ltd. 10% owner | 2022-11-29 | Option exercise | −1,723 | $0.00 | $0 | 1,121,045 | I |
| Pontifax Management 4 G.P. (2015) Ltd. 10% owner | 2022-11-29 | Option exercise | −1,914 | $0.00 | $0 | 1,226,412 | I |
| Derivatives | |||||||
| Pontifax Management 4 G.P. (2015) Ltd. 10% owner | 2022-11-29 | Option exercise · Call Options (obligation to sell) | −3,539 | 0 | I | ||
| Pontifax Management 4 G.P. (2015) Ltd. 10% owner | 2022-11-29 | Option exercise · Call Options (obligation to sell) | −1,723 | 0 | I | ||
| Pontifax Management 4 G.P. (2015) Ltd. 10% owner | 2022-11-29 | Option exercise · Call Options (obligation to sell) | −1,914 | 0 | I | ||
Loading xslF345X03/doc4.xml…